A systematic review on intrapyloric botulinum toxin injection for gastroparesis

Digestion

Volumn 81, Issue 1, 2010, Pages 27-34

  Bai, Yu ^a,b,c   Xu, Mao Jin ^d   Yang, Xia ^a   Xu, Can ^a,b   Gao, Jun ^a,c   Zou, Duo Wu ^a,b   Li, Zhao Shen ^a,b,c,d  

^a Department of Gastroenterology   (United Kingdom)

^b Digestive Endoscopy Center   (United States)

^c Center of Clinical Epidemiology   (Australia)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Botulinum toxin; Delayed gastric emptying; Gastroparesis; Intrapyloric botulinum toxin injection; Systematic literature review

Indexed keywords

BOTULINUM TOXIN; PLACEBO;

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCISEARCH; STATISTICAL SIGNIFICANCE; STOMACH EMPTYING; STOMACH PARESIS; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CLINICAL TRIALS AS TOPIC; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; INJECTIONS; PYLORUS; TREATMENT FAILURE;

EID: 72149119752     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235917     Document Type: Article

References (39)

1. Camilleri M: Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356: 820-829.
2. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, et al: The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225-1233.
3. Parkman HP, Hasler WL, Fisher RS; American Gastroenterological Association: American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1589-1591.
4. Sugumar A, Singh A, Pasricha PJ: A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis. Clin Gastroenterol Hepatol 2008; 6: 726-733.
5. Maganti K, Onyemere K, Jones MP: Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 2003; 98: 259-263.
6. Jones MP, Maganti K: A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003; 98: 2122-2129.
7. Montecucco C, Molgó J: Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol 2005; 5: 274-279.
8. Pasricha PJ, Ravich WJ, Kalloo AN: Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 1993; 105: 1045-1049.
9. Schiano TD, Parkman HP, Miller LS, et al: Use of botulinum toxin in the treatment of achalasia. Dig Dis 1998; 16: 14-22.
10. Antunes AA, Srougi M, Coelho RF, et al: Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol 2007; 4: 155-160.
11. Foschi D, Corsi F, Lazzaroni M, et al: Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond) 2007; 31: 707-712.
12. Mearin F, Camilleri M, Malagelada JR: Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925.
13. Ezzeddine D, Jit R, Katz N, et al: Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002; 55: 920-923.
14. Lacy BE, Zayat EN, Crowell MD, et al: Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002; 97: 1548-1552.
15. Bromer MQ, Friedenberg F, Miller LS, et al: Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833-839.
16. Tcherniak A, Kashtan DH, Melzer E: Successful treatment of gastroparesis following total esophagectomy using botulinum toxin. Endoscopy 2006; 38: 196.
17. Kent MS, Pennathur A, Fabian T, et al: A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy. Surg Endosc 2007; 21: 754-757.
18. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
19. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
20. Demets DL: Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 341-350.
21. Schulz KF, Chalmers I, Hayes RJ, et al: Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
22. Moher D, Pham B, Jones A, et al: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613. (Pubitemid 28380142)
23. Bai Y, Gao J, Zou DW, et al: Prophylactic antibiotics can not reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol 2008; 103: 104-110.
24. Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 (updated May 2005); in The Cochrane Library, Issue 3. Chichester, Wiley, 2005.
25. Miller LS, Szych GA, Kantor SB, et al: Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002; 97: 1653-1660.
26. Gupta P, Rao SS: Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. Gastrointest Endosc 2002; 56: 770- 772.
27. Woodward MN, Spicer RD: Intrapyloric botulinum toxin injection improves gastric emptying. J Pediatr Gastroenterol Nutr 2003; 37: 201-202.
28. Lacy BE, Crowell MD, Schettler-Duncan A, et al: The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004; 27: 2341-2347.
29. Ben-Youssef R, Baron PW, Franco E, et al: Intrapyloric injection of botulinum toxin A for the treatment of persistent gastroparesis following successful pancreas transplantation. Am J Transplant 2006; 6: 214-218.
30. Dumonceau JM, Giostra E, Bech C, et al: Acute delayed gastric emptying after ablation of atrial fibrillation: treatment with botulinum toxin injection. Endoscopy 2006; 38: 543.
31. Arts J, van Gool S, Caenepeel P, et al: Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 2006; 24: 661-667.
32. Arts J, Holvoet L, Caenepeel P, et al: Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258.
33. Friedenberg FK, Palit A, Parkman HP, et al: Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423.
34. Mirbagheri SA, Sadeghi A, Amouie M, et al: Pyloric injection of botulinum toxin for the treatment of refractory GERD accompanied with gastroparesis: a preliminary report. Dig Dis Sci 2008; 53: 2621-2626.
35. Stanghellini V, Tosetti C, Paternico A, et al: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-1042.
36. Parkman HP, Hasler WL, Fisher RS; American Gastroenterological Association: American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592-1622.
37. Leyden JE, Moss AC, MacMathuna P: Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev 2006:CD005046.
38. Revicki DA, Rentz AM, Dubois D, et al: Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-150.
39. Coleski R, Anderson MA, Hasler WL: Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci 2009 Jan 30. [Epub ahead of print].